LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 QL-XII-47
1.11
uM
LJP6
 2
O21
 72
hr
 1097 837 3769 0.2220 -0.0974
BT-20 QL-XII-47
1.11
uM
LJP6
 3
O21
 72
hr
 1097 908 3769 0.2409 -0.0708
BT-20 Radicicol
1.11
uM
LJP5
 1
K09
 72
hr
 1097 1251 3769 0.3319 0.0575
BT-20 Radicicol
1.11
uM
LJP5
 2
K09
 72
hr
 1097 1166 3769 0.3093 0.0257
BT-20 Radicicol
1.11
uM
LJP5
 3
K09
 72
hr
 1097 1085 3769 0.2878 -0.0046
BT-20 Radicicol
1.11
uM
LJP6
 1
K09
 72
hr
 1097 1132 3769 0.3003 0.0130
BT-20 Radicicol
1.11
uM
LJP6
 2
K09
 72
hr
 1097 1191 3769 0.3160 0.0351
BT-20 Radicicol
1.11
uM
LJP6
 3
K09
 72
hr
 1097 1320 3769 0.3502 0.0834
BT-20 Seliciclib
1.11
uM
LJP5
 1
J03
 72
hr
 1097 3254 3769 0.8632 0.8071
BT-20 Seliciclib
1.11
uM
LJP5
 2
J03
 72
hr
 1097 2937 3769 0.7791 0.6885
BT-20 Seliciclib
1.11
uM
LJP5
 3
J03
 72
hr
 1097 3054 3769 0.8102 0.7322
BT-20 Ruxolitinib
1.11
uM
LJP5
 1
O15
 72
hr
 1097 4065 3769 1.0784 1.1106
BT-20 Ruxolitinib
1.11
uM
LJP5
 2
O15
 72
hr
 1097 3995 3769 1.0598 1.0844
BT-20 Ruxolitinib
1.11
uM
LJP5
 3
O15
 72
hr
 1097 3943 3769 1.0460 1.0649
BT-20 XL147
1.11
uM
LJP5
 1
G09
 72
hr
 1097 3984 3769 1.0569 1.0803
BT-20 XL147
1.11
uM
LJP5
 2
G09
 72
hr
 1097 3986 3769 1.0574 1.0810
BT-20 XL147
1.11
uM
LJP5
 3
G09
 72
hr
 1097 3907 3769 1.0365 1.0514
BT-20 Saracatinib
1.11
uM
LJP6
 1
D09
 72
hr
 1097 2893 3769 0.7675 0.6720
BT-20 Saracatinib
1.11
uM
LJP6
 2
D09
 72
hr
 1097 2975 3769 0.7892 0.7027
BT-20 Saracatinib
1.11
uM
LJP6
 3
D09
 72
hr
 1097 2796 3769 0.7417 0.6357
BT-20 Selumetinib
1.11
uM
LJP6
 1
M09
 72
hr
 1097 3716 3769 0.9858 0.9800
BT-20 Selumetinib
1.11
uM
LJP6
 2
M09
 72
hr
 1097 3321 3769 0.8810 0.8322
BT-20 Selumetinib
1.11
uM
LJP6
 3
M09
 72
hr
 1097 3632 3769 0.9635 0.9485
BT-20 Sirolimus
1.11
uM
LJP6
 1
L15
 72
hr
 1097 2135 3769 0.5664 0.3883
BT-20 Sirolimus
1.11
uM
LJP6
 2
L15
 72
hr
 1097 2127 3769 0.5643 0.3853